|
|
|
Volumn 2, Issue 2, 2000, Pages 114-123
|
|
The evolving story of oral platelet glycoprotein IIb/IIIa receptor inhibitors
|
|
Author keywords
Acute coronary syndromes; Aspirin; Glycoprotein IIb IIIa inhibitors; Myocardial infarction; Platelet inhibitors
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
CROMAFIBAN;
EPTIFIBATIDE;
FRADAFIBAN;
GLYCOPROTEIN IIB;
GLYCOPROTEIN IIIA;
LEFRADAFIBAN;
LOTRAFIBAN;
N ETHYL N [4 (4 PIPERIDINYL)BUTYRYL]GLYCYLASPARTYL 3 CYCLOHEXYLALANINAMIDE;
ORBOFIBAN;
RECEPTOR BLOCKING AGENT;
ROXIFIBAN;
SIBRAFIBAN;
THIENOPYRIDINE;
TICLOPIDINE;
TIROFIBAN;
UNCLASSIFIED DRUG;
XEMILOFIBAN;
ATHEROSCLEROSIS;
BLEEDING;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
CORONARY STENT;
DOSE RESPONSE;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG TOLERABILITY;
HEART INFARCTION;
HUMAN;
RECEPTOR BLOCKING;
REVIEW;
THROMBOCYTOPENIA;
|
|
EID: 0034116889
PISSN: 14648482
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (59)
|
